Missing/wrong data?
Log in to edit
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
scientific article published on 31 August 2017
Author/s
author: Jürgen Rockstroh, Daniel Podzamczer, Adriano Lazzarin, Chloe Orkin, Pierre-Marie Girard
Work details
Publication date
August 31, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.